RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Focus Forward: The Tipping Point

Focus Forward: The Tipping Point

Posted 01 February 2011 | By

A few weeks ago, I attended a conference addressing the changing nature of the bio/pharmaceutical sectors, and particularly challenges in the regulatory approaches and the interface with reimbursement and economic factors.While the meeting focused most heavily on challenges in the US, many speakers and attendees emphasized that those same issues are shared around the world. Many at this meeting believed we are on the brink of major changes in the healthcare product sector.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.